Table of Contents
Hebron Pharmaceutical Group to create 25 new jobs in Miami-Dade County
Hebron Pharmaceutical Group, a pharmaceutical research and manufacturing company, will create 25 new jobs in Miami-Dade County with the opening of its first international sales office. The company made this decision after working alongside Miami-Dade Beacon Council.
The Brazil-based company is set to launch with an initial lease of 1,000 square feet at the Brazilian Trade and Investment Promotion Agency Miami office known as Apex-Brasil. In the coming years, Hebron plans to expand its footprint and eventually launch a manufacturing operation in Miami-Dade County.
“Having already settled our operation in Brazil and seeing the growth of sales in Latin America, the next strategic step for Hebron is the office in the USA,” stated Wedja Henrique Pires, Chief Marketing Officer of the Hebron Pharmaceutical Group.
“The Miami-Dade Beacon Council played a decisive role in our decision by providing specific data and analysis, reassuring the area’s great economic capacity, commercial integration and proving that Miami Dade County offers the ideal location for our plans. Given the current situation with COVID-19, strengthening America’s ability to produce pharmaceutical and healthcare products is vital and Hebron is willing and able to contribute,” stated Pires.
Hebron was founded in 1990 in the city of Caruaru, in northeast Brazil and now operates in more than 2,000 Brazilian cities with pharmaceutical representatives in more than half of these locations. With 40 products being traded, Hebron’s activities extend into the specialties of Pediatrics, Internal Medicine, Gastroenterology and Gynecology. The company focuses on both manufacturing pharmaceuticals as well as developing analytical processes and research in the above-mentioned specialty areas.
“Despite the current environment we have found ourselves in recently, the Miami-Dade Beacon Council is continuing to do the important work of growing our target industry sectors. With the recruitment of Hebron, we are growing our life science industry as well as strengthening our pharmaceutical supply chain,” stated Michael A. Finney, President & CEO of the Miami-Dade Beacon Council.
As the life science industry grows worldwide, opportunities for economic connections between Miami and Brazil, such as the example of Hebron, continue to occur. The United States is the largest pharmaceutical market in the world, and Brazil is the 7th largest and growing, according to InterFarma, a Brazilian non-profit that promotes health innovation in Brazil.
“We are excited to have Hebron Pharmaceutical Group locate at Apex-Brasil here in Miami-Dade County Commission District 5. Given the challenging environment our residents and workers are facing in the wake of the COVID-19 crisis, it’s encouraging to see innovative companies choosing to locate in our community with the promise of future economic growth and job opportunities for our residents,” stated District 5 County Commissioner Eileen Higgins.
